Activin-A and Interleukin-1β Levels in Periodontitis

计划入组 75 人 · 首次发布于 2023 年 10 月 31 日

Circulating Activin-A and FSTL3 in Precapillary Pulmonary Hypertension

计划入组 550 人 · 首次发布于 2025 年 11 月 28 日

Role of Activin A (ActA) in the Human Cancer Cachexia

计划入组 150 人 · 首次发布于 2012 年 5 月 24 日

Activin A modulator (chronic kidney disease)

activin type II receptor mAb (cachexia)

HS-135

Protein Sciences Corporation

United States

HOUSE OF SUPPLEMENTS AUSTRALIA PTY LTD

Australia

Sanofi-Aventis Deutschland Gmbh

Sweden

Merck's Winrevair Receives UK Approval for Pulmonary Arterial Hypertension

iBio Licenses First-in-Class Antibody Targeting Activin E for Obesity and Cardiometabolic Diseases

Keros Therapeutics Pauses Cibotercept Dosing in Higher Dose Arms of Phase 2 PAH Trial Due to Pericardial Effusion